Work for Simulations Plus, Inc.?

Claim Your Profile

Simulations Plus, Inc. Logo Image

Simulations Plus, Inc.

Simulations Plus, Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on

2018 Annual Report, Interactive Annual Report and Form 10K

Simulations Plus, Inc.


Simulations Plus, Inc. has reached its limit for free report views.

Upgrade your company profile to unlock all of your annual report content on

Archived Annual Reports

About Simulations Plus, Inc.

51-200 Employees
Based in Lancaster, California

Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. They partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval. With their subsidiaries, Cognigen Corporation and DILIsym Services, they offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, KIWI™, DILIsym®, NAFLDsym®, PKPlus™, and more) to bridge data mining, compound library screening with QSAR models, PBPK/TK modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. Simulations Plus technology is licensed to and used by regulatory agencies worldwide.

NASDAQ (See More NASDAQ Companies)
Healthcare Information Services (See More Healthcare Information Services Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol